...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: from IR/Chris
Reply New Message
Back To Forum List View
from IR/Chris
3
fuzzyjr
Dec 15, 2022 12:23PM
Re: from IR/Chris
2
KayakerBC
Dec 15, 2022 01:54PM

Just putting it out there but is it possible this 6% royalty stream is relatively new and put it in place  with expectation of a sale of Zenith Epigentics in the near future 

2 Recommendations
Re: from IR/Chris
1
KayakerBC
Dec 15, 2022 02:25PM
Re: from IR/Chris
1
fuzzyjr
Dec 15, 2022 03:10PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply